{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:52:32Z","timestamp":1790265152419,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008969","name":"Alfred Kordelinin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["220147"],"award-info":[{"award-number":["220147"]}],"id":[{"id":"10.13039\/100008969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["318422"],"award-info":[{"award-number":["318422"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["320102"],"award-info":[{"award-number":["320102"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["346122"],"award-info":[{"award-number":["346122"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007797","name":"Helsingin Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["101001734"],"award-info":[{"award-number":["101001734"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018703","name":"HORIZON EUROPE European Innovation Council","doi-asserted-by":"publisher","award":["101129886"],"award-info":[{"award-number":["101129886"]}],"id":[{"id":"10.13039\/100018703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007797","name":"University of Helsinki","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Preclinical biodistribution studies are required at an early stage of radiopharmaceutical development to determine tracer pharmacokinetics in clinically relevant animal models of human diseases. When combined with quantitative analysis from non-invasive imaging, biodistribution experiments provide essential data on the uptake, retention, binding specificity, metabolism, and clearance of radiotracers in both target and non-target tissues. Most research groups have developed in-house protocols to perform these studies in a reproducible manner. However, there is a general lack of consistency in how different groups carry out biodistribution experiments. In addition to practical differences that occur during tissue collection (for example, washing and blotting dry the tissue, perfusion, sampling site for a given tissue, etc.), other aspects of biodistribution experiments, which often vary include the methods used for calibrating the injected activity, the processes used to calculate mass normalized tissue uptake (i.e. percentage of injected dose per gram [%ID g\n                    <jats:sup>\u22121<\/jats:sup>\n                    ] or percentage of injected activity per gram of tissue [%IA g\n                    <jats:sup>\u22121<\/jats:sup>\n                    ]) values, differences in data processing and statistical analyses (particularly error propagations and calculation of tissue contrast ratios), and variations in how the methods and data are reported and interpreted. This variability hinders the direct comparison of datasets produced at different laboratories. Here, we present a comprehensive guideline for conducting\n                    <jats:italic>ex vivo<\/jats:italic>\n                    \u00a0biodistribution experiments with radiotracers in rodent models. An open source, freely accessible online biodistribution calculator and associated spreadsheet are provided which can be employed to compute the percent of injected dose per gram of tissue (%ID g\n                    <jats:sup>\u22121<\/jats:sup>\n                    ), standardized uptake value (SUV by mass), and target-to-background tissue contrast ratios. Finally, advice concerning biodistribution data presentation and statistical analysis are given to help the reader harness the full power of\n                    <jats:italic>ex vivo<\/jats:italic>\n                    biodistribution studies in radiotracer development.\n                  <\/jats:p>","DOI":"10.1007\/s11307-025-02055-8","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:12:55Z","timestamp":1761667975000},"page":"883-893","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Guide to Ex Vivo Biodistribution Studies with Radiotracers in Rodent Models"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2520-2146","authenticated-orcid":false,"given":"Surachet","family":"Imlimthan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4710-8129","authenticated-orcid":false,"given":"Cesare","family":"Berton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5496-0758","authenticated-orcid":false,"given":"Sophie","family":"Poty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0066-219X","authenticated-orcid":false,"given":"Jason P.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2956-4366","authenticated-orcid":false,"given":"Mirkka","family":"Sarparanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"2055_CR1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/ddr.10220","volume":"59","author":"MS Berridge","year":"2003","unstructured":"Berridge MS, Heald DL, Lee Z (2003) Imaging studies of biodistribution and kinetics in drug development. Drug Dev Res 59:208\u2013226. https:\/\/doi.org\/10.1002\/ddr.10220","journal-title":"Drug Dev Res"},{"key":"2055_CR2","unstructured":"International Atomic Energy Agency (2023) Guidance for preclinical studies with radiopharmaceuticals"},{"key":"2055_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11307-023-01868-9","volume":"26","author":"LM Carter","year":"2024","unstructured":"Carter LM, Zanzonico PB (2024) MIB guides: preclinical radiopharmaceutical dosimetry. Mol Imaging Biol 26:17\u201328. https:\/\/doi.org\/10.1007\/s11307-023-01868-9","journal-title":"Mol Imaging Biol"},{"key":"2055_CR4","doi-asserted-by":"publisher","unstructured":"Kunos CA, Howells R, Chauhan A, et al (2021) Radiopharmaceutical validation for clinical use. Front Oncol 11. https:\/\/doi.org\/10.3389\/fonc.2021.630827","DOI":"10.3389\/fonc.2021.630827"},{"key":"2055_CR5","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1471-2377-9-S1-S2","volume":"9","author":"KL Steinmetz","year":"2009","unstructured":"Steinmetz KL, Spack EG (2009) The basics of preclinical drug development for neurodegenerative disease indications. BMC Neurol 9:S2. https:\/\/doi.org\/10.1186\/1471-2377-9-S1-S2","journal-title":"BMC Neurol"},{"key":"2055_CR6","doi-asserted-by":"publisher","first-page":"v","DOI":"10.1016\/j.nucmedbio.2017.09.004","volume":"55","author":"HH Coenen","year":"2017","unstructured":"Coenen HH, Gee AD, Adam M et al (2017) Consensus nomenclature rules for radiopharmaceutical chemistry \u2014 setting the record straight. Nucl Med Biol 55:v\u2013xi. https:\/\/doi.org\/10.1016\/j.nucmedbio.2017.09.004","journal-title":"Nucl Med Biol"},{"key":"2055_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.nucmedbio.2020.11.003","volume":"93","author":"MM Herth","year":"2021","unstructured":"Herth MM, Ametamey S, Antuganov D et al (2021) On the consensus nomenclature rules for radiopharmaceutical chemistry \u2013 reconsideration of radiochemical conversion. Nucl Med Biol 93:19\u201321. https:\/\/doi.org\/10.1016\/j.nucmedbio.2020.11.003","journal-title":"Nucl Med Biol"},{"key":"2055_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cpet.2021.06.008","volume":"16","author":"B Ataeinia","year":"2021","unstructured":"Ataeinia B, Heidari P (2021) Artificial intelligence and the future of diagnostic and therapeutic radiopharmaceutical development. PET Clin 16:513\u2013523. https:\/\/doi.org\/10.1016\/j.cpet.2021.06.008","journal-title":"PET Clin"},{"key":"2055_CR9","first-page":"1836","volume":"36","author":"JW Keyes","year":"1995","unstructured":"Keyes JW (1995) SUV: standard uptake or silly useless value? J Nucl Med 36:1836\u20131839","journal-title":"J Nucl Med"},{"key":"2055_CR10","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.2967\/jnumed.107.050203","volume":"49","author":"P Zanzonico","year":"2008","unstructured":"Zanzonico P (2008) Routine quality control of clinical nuclear medicine instrumentation: a brief review. J Nucl Med 49:1114\u20131131. https:\/\/doi.org\/10.2967\/jnumed.107.050203","journal-title":"J Nucl Med"},{"key":"2055_CR11","first-page":"999","volume":"47","author":"BJ Fueger","year":"2006","unstructured":"Fueger BJ, Czernin J, Hildebrandt I et al (2006) Impact of animal handling on the results of 18F-FDG PET studies in mice. J Nucl Med 47:999\u20131006","journal-title":"J Nucl Med"},{"key":"2055_CR12","unstructured":"National Centre for the Replacement & Reduction of Animals in Research. ARRIVE guidelines. In: https:\/\/arriveguidelines.org\/"},{"key":"2055_CR13","doi-asserted-by":"publisher","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, et al (2020) The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol 18:e3000410. https:\/\/doi.org\/10.1371\/journal.pbio.3000410","DOI":"10.1371\/journal.pbio.3000410"},{"key":"2055_CR14","first-page":"251","volume-title":"Nuclear Medicine Physics: a Handbook for Teachers and Students","author":"RC Smart","year":"2014","unstructured":"Smart RC (2014) Physics in the radiopharmacy. In: Bailey DL, Humm JL, Todd-Pokropek A, van Aswegen A (eds) Nuclear medicine physics: a handbook for teachers and students. International Atomic Energy Agency, Vienna, pp 251\u2013286"},{"key":"2055_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trac.2018.10.019","volume":"110","author":"MM Moein","year":"2019","unstructured":"Moein MM, Nakao R, Amini N et al (2019) Sample preparation techniques for radiometabolite analysis of positron emission tomography radioligands; trends, progress, limitations and future prospects. TrAC Trends Anal Chem 110:1\u20137. https:\/\/doi.org\/10.1016\/j.trac.2018.10.019","journal-title":"TrAC Trends Anal Chem"},{"key":"2055_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-020-00692-4","volume":"10","author":"KK Ghosh","year":"2020","unstructured":"Ghosh KK, Padmanabhan P, Yang C-T et al (2020) Dealing with PET radiometabolites. EJNMMI Res 10:109. https:\/\/doi.org\/10.1186\/s13550-020-00692-4","journal-title":"EJNMMI Res"},{"key":"2055_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13550-020-00705-2","volume":"10","author":"F Li","year":"2020","unstructured":"Li F, Hicks JW, Yu L et al (2020) Plasma radio-metabolite analysis of PET tracers for dynamic PET imaging: TLC and autoradiography. EJNMMI Res 10:141. https:\/\/doi.org\/10.1186\/s13550-020-00705-2","journal-title":"EJNMMI Res"},{"key":"2055_CR18","volume-title":"The atomic nucleus","author":"RD Evans","year":"1972","unstructured":"Evans RD (1972) The atomic nucleus. McGraw-Hill Inc, New York"},{"key":"2055_CR19","volume-title":"Physics in Nuclear Medicine","author":"SR Cherry","year":"2012","unstructured":"Cherry SR, Sorenson JA, Phelps ME (2012) Physics in nuclear medicine,\u00a04th edn. Elsevier Inc"},{"key":"2055_CR20","first-page":"129","volume":"45","author":"M Miederer","year":"2004","unstructured":"Miederer M, McDevitt MR, Sgouros G et al (2004) Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates. J Nucl Med 45:129\u2013137","journal-title":"J Nucl Med"},{"key":"2055_CR21","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1158\/1078-0432.CCR-18-1650","volume":"25","author":"S Poty","year":"2019","unstructured":"Poty S, Carter LM, Mandleywala K et al (2019) Leveraging bioorthogonal click chemistry to improve 225Ac-radioimmunotherapy of pancreatic ductal adenocarcinoma. Clin Cancer Res 25:868\u2013880. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1650","journal-title":"Clin Cancer Res"},{"key":"2055_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48298-8","volume":"9","author":"RM de Kruijff","year":"2019","unstructured":"de Kruijff RM, Raav\u00e9 R, Kip A et al (2019) The in vivo fate of 225Ac daughter nuclides using polymersomes as a model carrier. Sci Rep 9:11671. https:\/\/doi.org\/10.1038\/s41598-019-48298-8","journal-title":"Sci Rep"},{"key":"2055_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s41181-022-00174-z","volume":"7","author":"D Castillo Seoane","year":"2022","unstructured":"Castillo Seoane D, De Saint-Hubert M, Ahenkorah S et al (2022) Gamma counting protocols for the accurate quantification of 225Ac and 213Bi without the need for a secular equilibrium between parent and gamma-emitting daughter. EJNMMI Radiopharm Chem 7:28. https:\/\/doi.org\/10.1186\/s41181-022-00174-z","journal-title":"EJNMMI Radiopharm Chem"},{"key":"2055_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/jlcr.3825","volume":"63","author":"VY Stenberg","year":"2020","unstructured":"Stenberg VY, Juzeniene A, Chen Q et al (2020) Preparation of the alpha-emitting prostate-specific membrane antigen targeted radioligand [212 Pb]Pb-NG001 for prostate cancer. J Labelled Comp Radiopharm 63:129\u2013143. https:\/\/doi.org\/10.1002\/jlcr.3825","journal-title":"J Labelled Comp Radiopharm"},{"key":"2055_CR25","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1006\/rtph.2000.1384","volume":"31","author":"W Steinke","year":"2000","unstructured":"Steinke W, Archimbaud Y, Becka M et al (2000) Quantitative distribution studies in animals: cross-validation of radioluminography versus liquid-scintillation measurement. Regul Toxicol Pharmacol 31:S33\u2013S43. https:\/\/doi.org\/10.1006\/rtph.2000.1384","journal-title":"Regul Toxicol Pharmacol"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-025-02055-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-025-02055-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-025-02055-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:37:57Z","timestamp":1768408677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-025-02055-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2055"],"URL":"https:\/\/doi.org\/10.1007\/s11307-025-02055-8","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"8 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}